Obstructive sleep apnea and atrial fibrillation (AFib) are two conditions that share a potentially deadly link. Having one increases the odds of developing the other, and together, the breathing ...

Catheter ablation significantly reduces cardiovascular risks and mortality in patients with both atrial fibrillation and obstructive sleep apnea. The study involved over 18,000 patients, showing a ...

AtriCure announced the successful first-in-human AFib treatments using its novel dual-energy surgical cardiac ablation platform.

Obstructive sleep apnea is associated with increased atrial fibrillation recurrence after ablation in patients with paroxysmal atrial fibrillation.

Combining pulsed field ablation and a radiofrequency technique in one platform is expected to reduce procedure times.

Johnson & Johnson MedTech will be one of several companies set to benefit from a new CMS decision related to pulsed field ...

Cardiac Ablation Market OverviewThe cardiac ablation market is set to grow at an impressive CAGR of approximately 13% over the forecast period, driven by a combination of clinical, technological, and ...